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Introduction: The majority of Australia’s burden of lung cancer
occurs in current or former tobacco smokers. To determine the
possible contribution of asbestos exposure in Australians presenting
with primary lung cancer, we measured lung asbestos content in
cases resected consecutively at a single cardio-thoracic hospital.
Methods: Asbestos bodies were quantified by lung tissue digestion,
filtration, and light microscopy, and were correlated with exposure
questionnaires and clinicopathological features.
Results: We demonstrate high intrarater reproducibility and inter-
rater reliability using these methods. In 463 patients with resected
primary lung cancers, asbestos content ranged from 0 to 749 asbes-
tos bodies per gram wet weight (AB/gww). Forty-eight percent of
patients had no asbestos bodies identified. One-third had less than or
equal to 20 AB/gww (a level previously found to be consistent with
urban dwelling). Nineteen percent had lung content in excess of this
level. Only 20 cases had AB 100/gww, approximately equivalent
to the Helsinki threshold for attribution of lung cancer to asbestos.
Median asbestos body counts were higher in patients who reported
previous asbestos exposure than in those who reported no exposure.
A subgroup of cases gave detailed exposure histories that did not
predict presence or absence of asbestos bodies in men or women. In
cases with cumulative tobacco exposure less than 20 pack-years,
asbestos body counts exceeding 20 AB/gww were overrepresented.
Conclusions: We found that the majority of patients with primary
lung cancer at a single Australian center have detectable asbestos in
resected lung tissue, but fiber burdens are generally low. The
contributory role of this low-level asbestos exposure in causing lung
cancer remains uncertain.
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Lung cancer is a major global health problem. It is theleading cause of cancer death in Australia, responsible for
22% of male cancer deaths and 15% of female cancer deaths
in 2004 and 5.3% of all deaths.1 Smoking is the largest single
cause of lung cancer, responsible for 85 to 90% of lung
cancers. The strength of this association and the prevalence of
smoking have contributed to difficulties with quantifying the
contribution of occupational carcinogen and atmospheric pol-
lutant exposures to an individual’s risk of lung cancer. The
precise contribution of asbestos exposure to the burden of
lung cancer in modern times is uncertain. Global estimates
are that 4 to 11% of lung cancers in industrialized nations are
attributable in part to occupational exposure to asbestos.2,3 In
the United States, an estimated 9 to 10,000 men and 9 to 1900
women develop lung cancer annually because of past expo-
sure to occupational carcinogens, and more than half of these
lung cancers are related to asbestos.4 In Australia, asbestos
was mined in Western Australia (Wittenoom 1938–1966) and
NSW (Baryulgil 1940–1979) and was imported from South
Africa and Canada. Perhaps the most extensive use of asbes-
tos product as housing stock in the world occurred in Aus-
tralia. It has been suggested approximately one in three
Australian homes built before 1987 and most public buildings
contain some form of asbestos.
Asbestos-related lung cancer has no unique clinical or
pathologic features that distinguish it from other lung can-
cers. Lower lobe predilection has been suggested, but is
controversial. The apparent adenocarcinoma subtype pre-
dominance mirrors that of lung cancers in general.5,6 In
addition to occupational histories, coexisting asbestos-related
pleural disease or asbestosis help to identify individuals with
significant past asbestos exposure. There is debate as to
whether lung cancer can be attributed to asbestos exposure in
the absence of asbestosis,7 with evidence both supporting8,9
and refuting10,11 this contention.
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Many asbestos-related lung cancers may result from the
combined effects of asbestos and carcinogens in tobacco smoke.
The causal interaction between asbestos and tobacco smoke has
been reported to vary from additive to multiplicative.12–14 Re-
cent reviews support a cumulative exposure model for lung
cancer risk as a consequence of asbestos exposure.7,15–18
To investigate the potential contribution of past asbes-
tos exposure to the current burden of lung cancer, we mea-
sured lung asbestos body counts in a large series of patients
undergoing resection for primary lung cancer.
Subjects
Patients gave informed written consent to participate in
this study, which was approved by The Prince Charles Hos-
pital Research Ethics Committee. The subjects were uns-
elected consecutive cases of primary lung cancer resected at
The Prince Charles Hospital. Preoperatively, patients were asked
whether they had ever been exposed to asbestos and responses
were recorded as “Yes,” “No,” or “I don’t know.” A subset of
patients completed a more-detailed questionnaire including job
matrices. The demographics, smoking, and clinical characteris-
tics of these subjects are summarized in Table 1.
METHODS
Tissue Digestion and Filter Preparation
Lung fiber burdens were assessed using a sodium hy-
pochlorite digestion and filtration technique.19 Fresh lung
tissue was collected from each patient’s resected lung at a
macroscopically normal site remote from the tumor. Lung
tissue was snap frozen in liquid nitrogen, and stored at
80°C. Cryopreserved lung (0.3 g) was weighed, cut into
1 to 2 mm pieces, and then digested in 10 mL of commercial
bleach (4.0–4.2% sodium hypochlorite) overnight on a
shaker until no visible particles remained in suspension, then
filtered through a 0.4 m, 25 mm Nucleopore polycarbonate
membrane (Crown Scientific, NSW, Australia) under nega-
TABLE 1. Demographics, Clinical, and Pathologic Characteristics of Primary Lung Cancer Cohort
Lung Asbestos Burden (AB/gww) 0 0–20 20–100 >100 All
Whole cohort 223 152 68 20 463
Gender, n (%)
Males 147 (66) 102 (67) 51 (75) 17 (85) 317 (68)
Females 76 (34) 50 (33) 17 (25) 3 (15) 146 (32)
Age (yrs), median (range)
66 (33–82) 70 (37–85) 69 (40–84) 71 (52–82) 67 (33–85)
Smoking status (Total pack-years)
Ever, n, median (range) 214, 46 (5–240) 144, 47 (3–225) 60, 45 (1–243) 18, 43 (15–94) 436, 45 (1–243)
Never, n 9 8 8 2 27
Reported asbestos exposure, n (%)
Yes 22 (10) 26 (17) 15 (23) 11 (55) 74 (16)
No 137 (61) 82 (54) 18 (26) 6 (30) 243 (52)
Unsure 15 (7) 7 (5) 9 (13) 0 (0) 31 (7)
No data 49 (22) 37 (24) 26 (38) 3 (15) 115 (25)
Resected lobe
RLL 22 23 8 2 55
RML 12 6 1 2 21
RUL 62 41 18 4 125
LLL 28 15 10 2 55
LUL 53 42 14 5 114
R Bi-lobe 11 70 50 2 25
R Lung 8 6 3 2 19
L Lung 25 10 9 1 45
Other (Lingula, Other Bi-lobe) 2 2 0 0 4
Tumour histology, n (%)
Adenocarcinoma 103 (46.2) 68 (44.7) 30 (44.1) 14 (70) 215 (46.4)
Squamous cell carcinoma 76 (34.1) 57 (37.5) 26 (38.2) 4 (20) 163 (35.2)
Adenosquamous carcinoma 15 (6.7) 4 (2.6) 3 (4.4) 0 (0) 22 (4.8)
Large cell undifferentiated 16 (7.2) 12 (7.9) 6 (8.8) 1 (5) 35 (7.6)
Bronchioloalveolar cell carcinoma 4 (2.0) 4 (2.6) 2 (3.0) 0 (0) 10 (2.1)
Other primary lung cancer 9 (4.0) 7 (4.6) 1 (1.5) 1 (5) 18 (3.9)
Cases were defined as “ever smokers” if there was a cumulative total of at least one pack-year. Cases were defined as “never smokers” if the cumulative total tobacco consumed
was less than one pack-year.
AB/gww, asbestos bodies counted by light microscopy per gram wet weight of lung tissue (see Methods section); total pack-years, number of years smoked number of cigarettes
per day/20; L, left; R, right; LUL, left upper lobe; LLL, left lower lobe; RUL, right upper lobe; RLL, right lower lobe; RML, right middle lobe; R Bi-lobe, right middle and upper
lobectomy OR right middle and lower lobectomy.
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tive pressure, using Millipore filtration apparatus. Aliquots of
digested tissue in suspension were treated with equal volumes
of 8% oxalic acid (Sigma, NSW, Australia), 100% ethanol
and bleach sequentially to remove organic residues, followed
by distilled water to prevent crystal deposition on the filter
surface. The filter was then rinsed with a final aliquot of
100% ethanol. Filters containing captured asbestos bodies
were affixed to coated glass slides, dried, dissolved with
chloroform, cover-slipped, and mounted.
Asbestos Body Counting
Slide mounted filter preparations were systematically
examined by light microscopy using a Nikon Eclipse E200
light microscope. The whole slide was scanned at 100
magnification to identify putative asbestos bodies then mor-
phology was confirmed at 400 magnification. Asbestos
bodies were identified by morphologic criteria: beaded ap-
pearance, thin translucent cores, bulbous ends, roughly par-
allel sides, and length greater than 20 to 50 m.20 Represen-
tative examples are shown in Figure 1.
Reliability and Reproducibility
To assess the interrater reliability of the asbestos body
counting procedure, 15% of tissue preparations (n 60) were
counted by three independent readers blind to the patient’s
self-reported exposure response and to the counts of the other
readers. Intrarater reproducibility was assessed by analysis of
asbestos body counts recorded for lung tissue preparations by
the same reader on two separate occasions without reference
to previous results. The mean intervals between repeat counts
were 66 days (reader 1), 58 days (reader 2), and 64 days
(reader 3).
Statistical Procedures
All statistical procedures were performed with SPSS
13.0 (SPSS Inc., Chicago, IL). Asbestos body counts were
not normally distributed and results are reported as median
and range. Nonparametric methods were used for analysis.
Reliability and reproducibility were analyzed using the SPSS
Reliability procedure to compute intraclass correlation coef-
ficients (ICC) for absolute agreement between counts.21,22 In
both analyses a two-way mixed effects model was used to
interpret the ICC for a single reader (as opposed to average
measures) as it was intended to indicate the suitability of
relying on a single rater’s count for the majority of samples.
The ICC has been interpreted by Fleiss as more than 0.75
excellent agreement, 0.4 to 0.75 fair-to-good agreement, and
less than 0.4 poor agreement.23 The null hypothesis was
rejected if the computed ICC was greater than 0.4 at a
significance level of p  0.05.
RESULTS
Interrater Reliability
The ICC for absolute interrater agreement between
three readers’ counts on 60 lung tissue samples was 0.93
(95% CI, 0.89–0.95; p  0.0001). Figure 2A shows the
asbestos body counts per gram wet weight of lung reported by
three readers on 60 lung samples.
Intrarater Reliability
The data for intrarater reproducibility consisted of two
separate counts of asbestos bodies per gram wet weight of
lung tissue on each of 23, 32, and 31 lung samples (readers 1,
2, and 3, respectively). The ICCs (95% CI) for absolute
agreement between repeated measurements were 0.933
(0.869–0.967) for reader 1, 0.987 (0.969–0.994) for reader
2, and 0.995 (0.990–0.998) for reader 3, p  0.0001 for all
(Figure 2B).
Asbestos Body Content in Lungs Resected for
Primary Cancer
Lung asbestos fiber burden was measured by light
microscopy in 463 consecutive cases (146 women and 317
FIGURE 1. Typical morphologic characteris-
tics of an asbestos body as viewed via light mi-
croscopy—beaded appearance, bulbous ends,
translucent cores roughly parallel sides, and
length 20–50 m.
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men) of primary lung cancer resected at The Prince Charles
Hospital between 2000 and 2006. From analysis of the
correlation between lung fiber burden measured by light
microscopy with detailed exposure histories in US residents
during the 1970s and 1980s, it was concluded that an asbestos
body count of 20 AB/gww was the upper limit associated
with urban dwelling without occupational or significant en-
vironmental asbestos exposure.24 We found lung asbestos
content equal to or greater than 20 AB/gww in 88 cases
(19%), up to 20 AB/gww in 152 cases (33%), and 0 AB/gww
in 223 (48%) of cases (Table 1). The age of patients with lung
burdens in excess of 20 AB/gww did not differ from that in
cases with low asbestos content (20 AB/gww) or those with
no asbestos detectable by the filter and light microscopy
method used here. In this cohort, women and men with
primary lung cancer had a similar distribution of lung asbes-
tos body counts (Figure 3).
Responses to the question whether they had asbestos
exposure were available for 348 of 463 cases of primary lung
cancer (75%). Most respondents reported no exposure (n 
243, 70% of respondents), 74 reported previous exposure
(21%), and 31 were uncertain (9%) (Table 1). Asbestos body
counts were significantly lower in individuals reporting no
prior exposure (median, 0 AB/gww; range, 0–749), than in
those who were able to recall past asbestos exposure (median,
8.4 AB/gww; range, 0–524; p  0.0001, Mann-Whitney
test); however, there was considerable overlap in lung fiber
content between these two groups. Detailed occupational and
environmental exposure questionnaire data were available for
77 primary lung cancer cases (17 women and 60 men).
Occupational exposure to asbestos was reported by almost
half of the men (29/60) but none of the women (0/17).
Among the 17 women with negative occupational history
questionnaires seven had asbestos bodies detected in lung
FIGURE 2. A, Intraclass correlation coefficient
(ICC) was computed for absolute agreement
using SPSS Reliability procedure using a two-
way mixed effects model. The null hypothesis
tested was that that ICC 0.4 (i.e., that inter-
reader reliability is low to moderate). ICC 
0.93 (0.89–0.95) indicated a high level of
agreement between these three readers, p 
0.0001. B, The mean interval between readings
was 66 days for reader 1, 64 days for reader 2,
and 58 days for reader 3. ICC was computed
using a two-way mixed model for absolute
agreement in SPSS Reliability procedure. p val-
ues tested the Null hypothesis that ICC 0.4
(i.e., that intrarater consistency is low to mod-
erate). Reader 1: ICC  0.933 (0.869–0.967),
p  0.0001, n  23; Reader 2: ICC  0.987
(0.969–0.994), p  0.0001, n  32; Reader
3: ICC  0.995 (0.990–0.998), p  0.0001,
n  31.
FIGURE 3. Y axes show asbestos body counts
on Log 10 scale. Reference line is positioned at
20 asbestos bodies per gram wet weight of
lung. (Values of 0 AB/gww for which log10
transformation could not be done were im-
puted as zero, for the purpose of graphically
displaying the complete distribution of values
on a log scale.) X-axis shows age in years.
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tissue, and in four the fiber burden was greater than 20
AB/gww. Eighty-three percent of men reporting occupational
exposure on the detailed questionnaire had asbestos bodies in
their resected lung (24/29). However, 39% of men (12/31)
returning negative exposure questionnaires also had detect-
able lung asbestos.
Lung fiber content did not differ significantly in relation
to the lobe resected (upper versus lower, p  0.455) nor to
laterality of the resection, (left versus right, p  0.806,
Mann-Whitney).
The spectrum of histologic subtypes of primary lung
cancer was similar between patients with lung asbestos con-
tent more than or equal to 20 AB/gww and those with less
than 20 or 0 AB/gww (Table 1).
Among cases of lung cancer with relatively low cumu-
lative tobacco exposure, asbestos body counts in excess of 20
AB/gww were over-represented (Pearson 2 8.875, df 1,
p  0.003, Table 2).
DISCUSSION
For the years 1987–2020, 30,000 to 79,000 cases of
lung cancer related to asbestos are predicted in Australia.25
Asbestos-related lung cancer is also an important compensa-
ble disease in Australia with payments made for dust-related
lung cancer in 2004–2005 (DDB NSW) in excess of
$A79m.26 The NSW compensation body recorded that deaths
from mesothelioma outnumbered deaths due to asbestos-
related lung cancer by 16.6:1.26 Given the overall prevalence
of the two diseases, lung cancer may be underrepresented
among compensated asbestos-related diseases in Australia.
We report results of lung asbestos burden in a contem-
porary and unselected cohort of patients undergoing resection
for primary lung cancer within the past 6 years. Within our
laboratory, quantification of asbestos bodies in resected lung
tissue is highly reproducible. Nineteen percent of an uns-
elected cohort from this single Australian center have fiber
burdens greater than expected for urban dwellers who have
not been occupationally or otherwise exposed to significant
respirable asbestos.24
Methodological Considerations
We counted only ferruginous bodies (“asbestos bod-
ies”), i.e., coated fibers with defined dimensions and mor-
phology. Although ferruginous bodies may form on amphi-
bole or chrysotile27–31 they most commonly form on
amphibole cores28,30,32–35 and mainly on longer fibers (8
m).36 The limited resolution of light microscopy means that
this technique cannot reliably detect short fibers (5 m) that
are usually uncoated37 or thin fibers (0.2 m). Therefore,
our light microscopic methods of counting asbestos bodies
are very likely to underestimate total lung asbestos fiber
content. Also, it cannot reliably identify the mineralogy of the
core fibers, and therefore retained chrysotile is not accurately
assessed by this method. A variable relationship between
uncoated fiber burden and ferruginous body counts among
individuals has been found in other studies.36,38 For these
reasons, and also because of the higher biopersistence of
amphibole in relation to serpentine asbestos in human lung39
our counts predominantly reflect amphibole exposure. We
recognize that an unknown and interindividually variable
proportion of “asbestos bodies” counted in this study may
have serpentine asbestos cores or nonasbestos fiber cores, and
that the proportion of amphibole fibers retained in lung that
are coated differs between individuals.
The quantification of lung asbestos burden by bleach
extraction and filtration may also not be directly comparable
with that obtained with hot “ashing,” although at least one
study has shown that fiber counts were not significantly
different between the two methods.40 Wet/dry lung weight
ratios were not measured for each sample. Instead, we relied
on previously reported estimates of these relationships to
extrapolate the Helsinki thresholds to an estimated equivalent
per gram wet weight of lung tissue.41 As the exact relation-
ship between wet and dry lung weight might be expected to
differ between individual samples, this extrapolation is an
approximation. However, considerable experimental consis-
tency in wet to dry lung weight ratios (approximately 7.5–10
fold) has been demonstrated previously42 making it less
probable that sample to sample variation in wet/dry lung
weight represents a major source of unaccounted error.
Despite the advantages of simplicity, low cost, and
reproducibility the method we used is not comparable with
electron microscopic methods of quantifying lung asbestos
content. The latter can both quantify the burden of uncoated
fibers and identify the composition of the fiber core but may
be subject to greater sampling error. Finally, we are currently
in the process of determining fiber burden in other cohorts
such as those with pleural plaques or asbestosis to establish
validated reference ranges for these various conditions, as
well as measuring the consistency of fiber content in different
anatomic regions of lung. Lung fiber content varies consid-
erably between different regions of the same lung (up to
10-fold), but data are based on studies of relatively few
individuals.43–47
Contemporary Significance of Lung Asbestos
Content in Primary Lung Cancer Patients
We noted a weak association between asbestos body
counts and self-reported asbestos exposure. It is likely that
responses were affected by numerous factors. Positive re-
sponses in cases with low lung fiber burden would be ex-
pected in cases of predominantly chrysotile exposure for
which lung fiber burden is a less accurate index than exposure
history, or in circumstances of long latency between exposure
TABLE 2. Relationship Between Smoking and Asbestos
Exposure in a Primary Lung Cancer cohort
Exposure Category
Smoking Category
Total0 or <20 pack-yrs >20 pack-yrs
0–20 AB/gww 53 (62.4) 332 (312.6) 375
20 AB/gww 24 (14.6) 64 (73.4) 88
Total 77 386 463
Pearson 2  8.875, df  1, p  0.003.
Expected values for each cell are shown in brackets.
AB/gww, asbestos bodies per gram wet weight; Pack-years, number of years
smoked multiplied by number of cigarettes per day divided by 20.
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and fiber burden determination. However, some individuals
may be referring to trivial exposure or exposure to asbestos in
nonrespirable forms. On the other hand, negative responses
may be returned when distant past exposure is not recalled, or
where the patient is unaware of exposure, e.g., childhood
exposure. For the cohort reported here, we have no systematic
corroborative evidence of past asbestos exposure such as
detailed occupational histories or presence or absence of
pleural plaques on CT scans. Because these correlations
provide important verification of exposure levels, we are now
prospectively collecting this data. A study from Germany
reported a highly variable relationship between work-place
exposure expressed in “fiber-years” and lung asbestos fiber
concentration48 where almost half of patients considered to
have asbestosis had cumulative work-place exposure of less
than 25 fiber-years.
Asbestos fibers are durable in lung tissue for many
years, but as a consequence of legislation prohibiting the
mining and milling of asbestos and the manufacture of new
asbestos products since the late 1960s, we expected younger
Australian patients to have significantly less exposure and
therefore lower lung fiber content. The age distribution of the
cohort indicates that the majority of patients were of working
age during the late 1960s. Of the 30 patients who were aged
less than 16 years in 1966, 14 had asbestos bodies detected in
resected lung, mostly with counts of less than 20 AB/gww.
These individuals were unlikely to have been exposed to
asbestos mining or manufacturing of new asbestos product,
but may have been exposed in building or construction,
demolitions, automotive, or other occupations where respira-
ble asbestos is generated from existing product. Childhood
exposure, such as in households with an occupationally
exposed parent, could explain the presence of asbestos at this
level in the lungs of these younger patients, but other types of
exposure associated with a low lung burden are not excluded.
It is worth noting that Australia differs from many European
countries in its extensive use of asbestos building products in
housing stock. The extent to which Australian householders,
including children, have been exposed to asbestos during
housing renovations is unknown.
We expected few women to have evidence of signifi-
cant past exposure to asbestos and surprisingly there was a
similar distribution of asbestos load in lung resected from
women and men. Lung fiber content in women was not
associated with self-reported exposure status. Of the 21
women with greater than 20 AB/gww lung, only four had
given detailed occupational exposure information, but none
reported either personal occupational exposure or an occupa-
tionally exposed spouse. The lung fiber content in these
women is not explained by recalled asbestos exposure. As-
bestos product manufacture was conducted in Brisbane sub-
urbs within 5 km of the center from which this cohort was
drawn until the mid 1960s. Urban dwelling in such a vicinity
is a possible explanation for this observation but residential
information on these cases is not available to us. Mesotheli-
oma rates associated with environmental exposure to crocido-
lite in Wittenoom, Western Australia, recently described by
Reid et al.,49 indicated steeper dose response curves for
women than for men. An association between lung cancer
and environmental asbestos exposure has never been de-
scribed, and would be difficult to recognize in individuals
with concurrent active or passive tobacco exposure.
The Helsinki criteria for lung cancer estimate that
cumulative exposure of 25 fiber-years (1 fiber/cm3 for 1
year  1 fiber-year) increases the risk of lung cancer 2-fold,
and relates this risk to retention of 2 million amphibole fibers
more than 5 m or 5 million amphibole fibers more than 1
m per gram dry lung tissue as assessed by electron micros-
copy.50 This is approximately equivalent to 5000 to 15,000
asbestos bodies per gram dry tissue, and to 500 to 1500
asbestos bodies per gram wet weight lung.42 Only two lung
cancer patients in this cohort had fiber burdens in this range.
Extrapolation of the Helsinki criteria indicates that more than
100 asbestos bodies per gram wet tissue identifies persons
with a high probability of exposure to asbestos dust at work.
Twenty lung cancer patients in this cohort (17 men and 3
women) had lung asbestos content in this range, representing
only 4.3% of the total. Women with lung asbestos content in
the “occupational exposure” range did not report previous
asbestos exposure and may have been unaware of it. The
finding of greater than 20 asbestos bodies per gram wet
weight in a disproportionately high number of lung cancer
cases in this cohort with less than 20 pack years of cumulative
tobacco exposure, raises the issue of whether asbestos con-
tributed materially to lung cancer risk in these individuals.
The Helsinki criteria have recently been criticized on
the basis that (1) they are derived from studies in which
exposure levels derived from years of employment in partic-
ular occupations or general environmental levels are crude
estimates of actual exposure in individuals, (2) they fail to
take account of differing risk due to different fiber types, and
(3) they do not provide for variation in assessment of lung
fiber burden due to different measurement methodologies
between laboratories.51 Notwithstanding this, we considered
direct measurement of fiber burden in lung tissue to have
advantages over the more indirect approach of estimating
exposure from occupational histories for investigating the
relationship between asbestos exposure and lung cancer,
particularly in Australia where most exposure included a
significant component of amphibole.
Animal models have not provided strong evidence that
fiber mineralogy independent of fiber dimensions is respon-
sible for differential fiber carcinogenicity. Rodent animal
models have the disadvantage of short animal life-span in
relation to fiber retention and durability in tissue and there-
fore do not faithfully represent human fiber carcinogenesis.
On the other hand human epidemiological studies provide
consistent evidence that chrysotile is less potent than amphi-
boles for induction of mesothelioma and also (to a lesser
extent) lung cancer. The disadvantage of the human epide-
miological studies is that the exact fiber composition of
exposure is often not precisely known. Nevertheless from
published epidemiology studies crude aggregate percentages
of mesothelioma cases among cohorts of workers exposed to
amphiboles, mixed fiber types, and chrysotile were recently
reported as 1.23%, 0.67%, and 0.04%, respectively.52 The
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fact that the diagnoses in the cases among chrysotile workers
were unconfirmed is relevant to the contentious issue of
whether exposure to chrysotile with its 40 times lower biop-
ersistence than crocidolite in animal studies53 is carcinogenic
in humans, except under conditions of intense repeated ex-
posures. Exposure specific excess lung cancer mortality esti-
mates in cohorts exposed to amphiboles, mixed asbestos, and
chrysotile of 2 to 10%, 0.32%, and 0.5% per f/ml yr,
respectively indicated a clear fiber type risk gradient for lung
cancer in occupational cohort studies analyzed by Hodgson
and Darnton.16
In summary, we have demonstrated reproducible lung
asbestos fiber counts in a large cohort of Australian patients
undergoing resection for lung cancer since the year 2000. We
found that approximately half of these patients had no lung
asbestos detectable by light microscopy, one-third had body
counts below 20 AB/gww, one-fifth had body counts exceed-
ing 20 AB/gww, and only two patients had body content
above 500 AB/gww (approximated Helsinki threshold for
causal attribution of lung cancer). We found no significant
differences in distribution of demographic variables, lung
cancer lobar location, or histologic subtypes based on lung
asbestos fiber content in this cohort. The retained asbestos
fiber burden in the lungs of this contemporary series of
patients undergoing resection for lung cancer is very low in
comparison with the lung burden epidemiologically associ-
ated with increased lung cancer risk, indicating that asbestos
is not likely to be a major causal contributor to lung cancer in
the majority of the cases. However, the true extent to which
even low level asbestos exposure interacts with tobacco
exposure in human lung carcinogenesis remains unknown.
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